Table 6 Comparison of outcomes according to the follow-up periods.
Follow-up (years) | Total number of patients treated with ZES (n) | Total number of patients treated with SES, PES or EES (n) | Type of DES versus ZES | Analytic report (RR with 95% CI) |
---|---|---|---|---|
2 years | 1222 | 1213 | SES versus ZES | No significant difference was observed in ST |
2 years | 1383 | 1384 | PES versus ZES | |
2 years | 2100 | 2098 | EES versus ZES | — |
3 years | 150 | 154 | SES versus ZES | — |
4 years | 1140 | 1152 | EES versus ZES | — |
4 years | 1174 | 1236 | SES versus ZES | Definite or probable ST significantly favored ZES [1.98 (1.22–3.23); p = 0.006 |
5 years | 1469 | 1278 | SES versus ZES | |
5 years | 921 | 915 | PES versus ZES |